Newsroom
News
Cardiosense in the press: clinical milestones, FDA authorizations, executive announcements, and coverage of our work on noninvasive cardiac monitoring.
-
May 28, 2026 Cardiovascular Business
FDA gives greenlight to new AI tool for managing heart failure patients
Read now
-
May 27, 2026 Becker's ASC Review
FDA clears catheter-free heart failure monitor
Read now
-
May 27, 2026 Medical Economics
Cardiosense receives FDA authorization for heart failure monitoring software
Read now
-
May 27, 2026 HCPLive
FDA Grants De Novo Status to Cardiosense PCWP Software for HFrEF
Read now
-
May 27, 2026 Business Wire
Cardiosense Receives FDA De Novo Classification for Novel Cardiac Technology Designed to Improve Care for Patients with Heart Failure
Read Now
-
November 6, 2025 Business Wire
Cardiosense Presents New Analysis of the SEISMIC-HF I Study Validating its AI Algorithm for Noninvasive PCWP Assessment at the American Heart Association’s 2025 Scientific Sessions
Read now
-
October 28, 2025 Business Wire
Cardiosense Presents New Clinical Analysis of SEISMIC-HF I Data on AI-Enabled Volume Assessment in Heart Failure at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 Scientific Symposium
Read now
-
September 18, 2025 Business Wire
Cardiosense Appoints Eric Meizlish as CEO to Advance AI-Enabled Cardiac Care
Read now
-
August 12, 2025 Business Wire
Cardiosense Appoints Medtech Executive John Martin, MD as EVP and Chief Medical Officer
Read now
-
July 30, 2025 Business Wire
Cardiosense Receives FDA 510(k) Clearance for the CardioTag™ Device, Paving the Way for Advanced Cardiac Function Monitoring
Read now
-
June 25, 2025 Business Wire
Cardiosense Announces Publication of SEISMIC-HF I Study Results in the Journal of the American College of Cardiology: Heart Failure
Read now
-
May 28, 2025 Business Wire
Cardiosense Launches Nationwide SEISMIC-HF II Study to Validate Its AI Algorithm for Non-Invasive Heart Failure Management
Read now
-
May 22, 2025 MedTech Strategist
Cardiosense Noninvasively Measures Heart Failure’s Key Warning Signal
Read now
-
November 20, 2024 PR Newswire
Results from Cardiosense’s SEISMIC-HF I Study of a Machine Learning Model to Non-Invasively Assess Cardiac Filling Pressure Presented as Late-Breaking Science at American Heart Association’s 2024 Scientific Sessions
Read now
-
October 29, 2024 PR Newswire
Cardiosense Presents Interim Clinical Study Data for Machine Learning Algorithm to Aid in Heart Failure Management at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 Scientific Symposium
Read now
-
May 14, 2024 GlobeNewswire
Cardiosense CardioTag™ Named “Best IoT Healthcare Wearable Device” in 8th Annual MedTech Breakthrough Awards Program
Read now
-
October 3, 2023 PR Newswire
Cardiosense Begins Enrollment in Nationwide Heart Failure Study
Read now
-
December 14, 2022 Fierce Biotech
Cardiosense lands $15M for AI to predict worsening heart disease from wearables
Read now
-
December 8, 2022 PR Newswire
Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance AI Platform for Heart Disease
Read now
-
April 13, 2022 Lab Rats to Unicorns
Dr. Omer Inan shares insight on academia and entrepreneurship – for example, how do they interact…and can a person pursue both?
Listen now
-
February 15, 2022 PR Newswire
Cardiosense receives FDA Breakthrough Device designation for algorithm to identify patients at risk of decompensated heart failure
Read now
-
December 8, 2020 Texas Medical Center
TMCx has progressed virtually in 2020 including Bootcamp, an intensive diligence and relationship building period designed to initiate…
Read now